Physician profile
Danielle Johnson
NPI 1174104087
$4,224.08
in general payments reported to CMS, 2019-2025
18 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $142 · 2023: $2,902 · 2024: $524 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065 · Travel and Lodging: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.32 |
| Travel and Lodging | $1,810.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $2,619.29 | 2023-2024 | Xeomin |
| Abbvie INC. | $406.15 | 2023-2025 | |
| Biotronik Nro, INC. | $279.42 | 2024 | Prospera |
| Inspire Medical Systems, INC. | $142.97 | 2025 | Inspire |
| Revance Therapeutics, INC. | $133.46 | 2025 | Daxxify |
| Genzyme Corporation | $126.69 | 2024 | |
| Astellas Pharma US INC | $114.38 | 2021-2023 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.16 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $56.95 | 2022 | |
| Galderma Laboratories, L.P. | $50.62 | 2024-2025 | |
| Mylan Specialty L.P. | $49.30 | 2021-2022 | |
| Pfizer INC. | $46.37 | 2021-2022 | |
| Lilly USA, LLC | $41.17 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.86 | 2024 | Relistor |
| Currax Pharmaceuticals LLC | $15.83 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.13 | 2021 | |
| Amarin Pharma, INC. | $12.93 | 2021 | |
| Horizon Therapeutics Plc | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.